Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

 

PleXus Communications
Avatar

HR+ Breast Cancer: Individualizing Therapy With CDK 4/6 Inhibitors

By PleXus Communications FEATURING Komal Jhaveri
By PleXus Communications FEATURING Komal Jhaveri
346 views
February 9, 2022
This activity is supported by an educational grant from Lilly. For further information concerning Lilly ...
read more ↘
Comments 1
Login to view comments. Click here to Login

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Featured Video

13:36
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Feat. J. Gutierrez, J. Strauss
Breast
13:16

SABCS 2024 Insights: EMBER-3 Trial - Imlunestrant Monotherapy and Co…

2024 SABCS Annual Meeting Insights Hub

K. Jhaveri

226 views
06:39

FDA Approval Clinical Implications: Inavolisib With Palbociclib and …

Memorial Sloan Kettering Cancer Center

K. Jhaveri

1.1K views
06:55

ESMO 2023 Insights: "EMBER Study - Imlunestrant+/-Everolimus or Alpe…

Insights from 2023 ESMO Annual Meeting

K. Jhaveri

159 views
21:26

Early Diagnosis and Updates in Breast Cancer

Memorial Sloan Kettering Cancer Center

V. Sacchini

171 views
27:27

ASCO 2022 HR+ Breast Cancer Updates

Nebraska Oncology Society

C. Dang

599 views
05:51

ASCO 2022 on the Phase 3 DESTINY-Breast 03 Trial: HER2+ BC Updates

Nebraska Oncology Society

C. Dang

56 views
09:47

ASCO 2022 on the Phase 3 KEYNOTE-522 Trial: TNBC Updates

Nebraska Oncology Society

C. Dang

77 views
09:57

ASCO 2022 Preliminary Analysis of an Expanded Access Study of the Fi…

ASCO 2022 Conference Coverage

C. Dang

201 views
01:06

Lecture Summary - ASCO 2022 Preliminary Analysis of an Expanded Acce…

ASCO 2022 Conference Coverage

C. Dang

43 views
05:41

ASCO 2022 DESTINY-Breast04: Trastuzumab Deruxtecan Doubles PFS in MB…

ecancer

S. Modi

43 views
05:57

ASCO 2022 DESTINY-Breast04: Trastuzumab Deruxtecan vs. Treatment of …

ecancer

S. Modi

223 views
06:32

ASCO 2022 on Characterization of Alpelisib-Associated Hyperglycemia …

ASCO 2022 Conference Coverage

S. Shen

368 views
01:37

Lecture Summary - ASCO 2022 on Characterization of Alpelisib-Associa…

ASCO 2022 Conference Coverage

S. Shen

18 views
20:08

HER2- Directed Targeted Agents for Brain Metastasis in Metastatic Br…

Memorial Sloan Kettering Cancer Center

N. Iyengar

662 views
28:05

2022 Inherited Breast Cancer Risk Assessment and Reduction: What's N…

University of Kansas Cancer Center Post San Antonio Review

M. Robson

47 views
53:46

HR+ Breast Cancer: Individualizing Therapy With CDK 4/6 Inhibitors

PleXus Communications

K. Jhaveri

346 views
07:16

SABCS 2021 Results of a Prospective Screening Study: Impact of Race …

SABCS 2021 Conference Coverage on VuMedi

A. Barrio

17 views
13:08

SABCS 2021 Updates on Neratinib + Fulvestrant + Trastuzumab for HR+/…

SABCS 2021 Conference Coverage on VuMedi

K. Jhaveri

281 views
24:21

SABCS 2021 Update on Oligoprogressive Disease in BC: Treating Locall…

SABCS 2021 Conference Coverage on VuMedi

A. Xu

509 views
20:23

Will Surgery Be a Part of Breast Cancer Treatment in the Future?

Memorial Sloan Kettering Cancer Center

M. Morrow

3.8K views
26:50

CAR-T Cell Therapy for Breast Cancer: Types of T-Cell Therapy, Ident…

5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure

S. Modi

829 views